SI1487424T1 - 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases - Google Patents

4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases

Info

Publication number
SI1487424T1
SI1487424T1 SI200330576T SI200330576T SI1487424T1 SI 1487424 T1 SI1487424 T1 SI 1487424T1 SI 200330576 T SI200330576 T SI 200330576T SI 200330576 T SI200330576 T SI 200330576T SI 1487424 T1 SI1487424 T1 SI 1487424T1
Authority
SI
Slovenia
Prior art keywords
ang
methylpiperazin
benzamide
pyrimidin
ylmethyl
Prior art date
Application number
SI200330576T
Other languages
Slovenian (sl)
Inventor
Richard Ernest Gilbert
Darren James Kelly
David Louis Feldman
Original Assignee
Novartis Ag
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0206217A external-priority patent/GB0206217D0/en
Priority claimed from GB0206216A external-priority patent/GB0206216D0/en
Priority claimed from GB0217505A external-priority patent/GB0217505D0/en
Application filed by Novartis Ag, Univ Melbourne filed Critical Novartis Ag
Priority claimed from PCT/EP2003/002709 external-priority patent/WO2003077892A2/en
Publication of SI1487424T1 publication Critical patent/SI1487424T1/en

Links

SI200330576T 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases SI1487424T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0206217A GB0206217D0 (en) 2002-03-15 2002-03-15 Organic compounds
GB0206216A GB0206216D0 (en) 2002-03-15 2002-03-15 Organic compounds
GB0217505A GB0217505D0 (en) 2002-07-29 2002-07-29 Organic compounds
PCT/EP2003/002709 WO2003077892A2 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases
EP03727265A EP1487424B1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases

Publications (1)

Publication Number Publication Date
SI1487424T1 true SI1487424T1 (en) 2007-04-30

Family

ID=37998607

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330576T SI1487424T1 (en) 2002-03-15 2003-03-14 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases

Country Status (1)

Country Link
SI (1) SI1487424T1 (en)

Similar Documents

Publication Publication Date Title
TWI347186B (en) Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
IL181674A0 (en) Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
IS8340A (en) Multiple Images 3- (4-Amino-1-oxo-1,3 dihydro-isoindol-2-yl) -piperidine-2,6-dione
EP1558148A4 (en) Surgical fastener particularly for the treatment of gastroesophageal reflux disease (gerd)
AP2006003621A0 (en) Methods for treatment modification and management of pains using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoin-doleline
SI1701944T1 (en) 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
ZA200804030B (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
HK1078779A1 (en) Substituted benzazoles and use thereof as raf kinase inhibitors
EP1641748A4 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
NO2013001I2 (en) Dabigatran etexilate and its salts; especially dabigatran etexilate mesylate
IL164678A (en) High drug load tablet comprising 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide or phamaceutically acceptable salt thereof and process for its preparation
EP1806338A4 (en) Process for producing 2-amino-2-[2-[4-(3-benzyloxy­phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
HK1078007A1 (en) Pramipexole once-daily dosage form
WO2002034727A3 (en) Treatment of gastrointestinal stromal tumors
SI1651622T1 (en) Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds
AU2003232960A1 (en) 4-4(methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating mutated-ret kinase associated diseases
PL1651604T3 (en) N-´2-(2-pyridinyl)ethyl benzamide compounds and their use as fungicides
IL178785A0 (en) Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension
AU2003233946A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
DE60226512D1 (en) CASSETTE FOR SAVING MULTIPLE SEMICONDUCTOR WAECTS
DE50303099D1 (en) Patient table
TWI350753B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
DE60311035D1 (en) pusher
AU2003244922A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
SI1487424T1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases